GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 21, 2024
Displaying entries 9251 - 9300 of 39437 in total
PDB ID UniProt ID ▼ Title Descriptor
7UAI Q16819 Meprin alpha helix in complex with fetuin-B
3IAI Q16790 Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX
6Y74 Q16790 X-ray crystal structure of human carbonic anhydrase IX catalytic domain.
3SI0 Q16769 Structure of glycosylated human glutaminyl cyclase
5SC8 Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 17
5SC9 Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 29
5SCA Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 36
5SCB Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 28
5SCC Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 57
5SCD Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 58
5SCE Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 55
5SCF Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 99
5SCG Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 101
5SCH Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 100
5SCI Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 105
5SCJ Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 106
5SCK Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 42
5SCL Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 1
5SDT Q16716 Structure of liver pyruvate kinase in complex with anthraquinone derivative 15
7L0J Q16671 Structure of AMH bound to AMHR2-ECD
3B6H Q16647 Crystal structure of human prostacyclin synthase in complex with inhibitor minoxidil
2FO4 Q16615 Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical tumor associated MUC1-8 peptide
6UXO Q16611 Crystal structure of BAK core domain BH3-groove-dimer in complex with DDM
6D1U Q16602 Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer in complex with adrenomedullin 2/intermedin
6ZHO Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer with bound high affinity inhibitor
6ZIS Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer with bound high affinity inhibitor
5V6Y Q16602 Crystal structure of the human CLR:RAMP1 extracellular domain heterodimer with bound high-affinity and altered selectivity adrenomedullin variant
6V2E Q16602 Crystal structure of the human CLR:RAMP2 extracellular domain heterodimer with bound high-affinity adrenomedullin S45R/K46L/S48G/Q50W variant
7P0F Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0028125
7P0I Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor Compound 13
4RWF Q16602 Crystal structure of the CLR:RAMP2 extracellular domain heterodimer with bound adrenomedullin Maltose transporter subunit, Receptor activity-modifying protein 2, Calcitonin gene-related peptide type 1 receptor fusion protein, adrenomedullin
4RWG Q16602 Crystal structure of the CLR:RAMP1 extracellular domain heterodimer with bound high affinity CGRP analog
8AX5 Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029881
8AX6 Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0029882
8AX7 Q16602 Crystal structure of a CGRP receptor ectodomain heterodimer bound to macrocyclic inhibitor HTL0031448
4HSA Q16552 Structure of interleukin 17a in complex with il17ra receptor Interleukin-17A, Interleukin-17 receptor A
5N92 Q16552 Crystal Structure of Human IL-17AF Interleukin-17A, Interleukin-17F
5NAN Q16552 Crystal Structure of human IL-17AF in complex with human IL-17RA
7UWM Q16552 Structure of the IL-17A-IL-17RA binary complex
7UWN Q16552 Structure of the IL-17A-IL-17RA-IL-17RC ternary complex
7ZAN Q16552 Crystal Structure of human IL-17A in complex with IL-17RA and IL-17RC
5TCO Q16539 Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1
6HWU Q16539 Crystal structure of p38alpha in complex with a photoswitchable 2-Azothiazol-based Inhibitor (compound 2)
6HWT Q16539 Crystal structure of p38alpha in complex with a reduced photoswitchable 2-Azothiazol-based Inhibitor (compound 31)
6QYX Q16539 p38(alpha) MAP kinase with the activation loop of ERK2
6HWV Q16539 Crystal structure of p38alpha in complex with a photoswitchable 2-Azoimidazol-based Inhibitor (compound 3)
1ZYJ Q16539 Human P38 MAP Kinase in Complex with Inhibitor 1a
1ZZ2 Q16539 Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes
2FSL Q16539 mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A
2FSM Q16539 mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024